Table 1.
Summary of included studies
Study | Country | Recruitment | Clinic/community | Diabetes/metabolic syndrome | Duration of FUP | Outcomes | Quality score (/10) |
---|---|---|---|---|---|---|---|
Artero [49] | France | Random sample recruited from French electoral roles | Community | Diabetes | 4 years | All cause dementia | 10 |
Ciudin [50] | Italy | Patients attending a memory clinic, Fundacio ACE, aged > 60 with type 2 diabetes | Clinic | Diabetes | 2 years | All cause dementia | 4 |
Exalto et al. [51] | Netherlands | Recruited from a memory clinic based Amsterdam Dementia Cohort of VU University Medical Centre | Community | Metabolic syndromea | 0.6–4.6 years | All cause dementia | 8 |
Li et al. [52] | China | Subjects were sampled from ten randomly selected communities in the city of Chongqing | Clinic | Diabetes | 5 years | Conversion to Alzheimer’s dementia | 8 |
Ma et al. [53] | China | Recruitment from six geographically convenient communities with high proportions of elderly residents within Tianjin city, China | Community | Diabetes | 4 years | All cause dementia | 7 |
Morris et al. [54] | USA | Data were obtained from ADNI on 5 January 2012. ADNI is conducted by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, pharmaceutical companies, and nonprofits | Clinic | Diabetes | 2 years | Conversion to Alzheimer’s dementia | 8 |
Ng et al. [55] | Singapore | Participants were of Chinese ethnicity and recruited from five districts in the South East region of Singapore from September 1, 2003 to December 31, 2009 | Community | Metabolic syndromeb and diabetes | 4 years | All cause dementia | 8 |
Prasad et al. [56] | Singapore | Retrospective analyses of a prospective clinical database comprising patients with cognitive impairment managed at the memory clinic of a tertiary neurology center between January 2008 and January 2011 | Clinic | Diabetes | Minimum 18 months | Conversion to Alzheimer’s dementia | 4 |
Ravaglia et al. [57] | Italy | Participants were recruited among the outpatients seeking medical advice for cognitive complaints at the Center for Physiopathology of Aging, University of Bologna | Clinic | Diabetes | From 6 months to 5 years | All cause dementia | 4 |
Solfrizzi et al. [58] | Italy | A sample of 5632 subjects aged 65–84 years, independent or institutionalized, was randomly selected from the electoral rolls of eight Italian municipalities, after stratification for age and gender | Community | Metabolic syndromea | 3 years | All cause dementia | 7 |
Velayudhan et al. [59] | UK | Potential candidates were identified from general practice registers and invited to participate. Participants were assessed annually from 2001 to 2007 | Clinic | Diabetes | 4 years | All cause dementia | 5 |
Xu et al. [48] | Sweden | Participants recruited from all registered inhabitants who were age 75 years or older and living in the Kungsholmen district of central Stockholm, Sweden, in 1987 | Community | Diabetes | 9 years | All cause dementia | 6 |
aMetS diagnosis: ATPIII criteria—3 or more of the following components abdominal obesity (waist circumference > 102 cm for men and > 88 cm for women); elevated plasma triglycerides (≥ 150 mg/dL); low HDL cholesterol (< 40 mg/dL for men and < 50 mg/dL for women); high blood pressure(≥ 130/≥85 mmHg) or being in hypertensive treatment; high fasting plasma glucose (≥ 110 mg/dL)
bMetS diagnosis: International Diabetes Federation criteria—central obesity (waist circumference ≥ 90 cm for men and ≥ 80 cm for women) plus at least 2 CVRFs, including raised triglyceride levels (≥ 150 mg/dL) or specific treatment for this lipid abnormality; reduced high-density lipoprotein cholesterol level (< 40 mg/dL in men and < 50 mg/dL in women) or specific treatment for this lipid abnormality; raised blood pressure (systolic ≥ 130 mm Hg or diastolic ≥ 85 mm Hg or treatment of previously diagnosed hypertension) and raised fasting plasma glucose level (≥ 100 mg/dL or previously diagnosed type 2 diabetes mellitus)